| - Industry | - Sector | - CEO | MSE Exchange | - ISIN |
| India Country | 70 Employees | - Last Dividend | 12 May 2026 Last Split | - IPO Date |
Aptus Pharma Limited is a publicly listed pharmaceutical company dedicated to the marketing and distribution of finished pharmaceutical formulations. The company operates on an asset-light contract manufacturing model, collaborating with certified third-party manufacturers to ensure compliance with cGMP and WHO-GMP protocols. This strategy allows Aptus Pharma to maintain high-quality standards without the burden of owning production facilities. The company has developed a diversified portfolio comprising over 194 products across various therapeutic areas. Aptus Pharma is structured into four primary divisions tailored to specific healthcare needs: the Pioneer Division, Cardiac Diabetic Division, Wellcare Division, and Global Division, each catering to acute and chronic therapies, wellness products, and export markets. With a robust distribution network encompassing more than 125 distributors and over 6,500 healthcare professionals, Aptus Pharma has established a significant presence in Gujarat and is actively expanding into other Indian states and emerging global markets. The company utilizes centralized warehousing for efficient inventory management and is widely recognized for its flagship brand “Chilkul.” Aptus Pharma's commitment to market reach, product diversity, and stringent quality assurance significantly enhances its role in India’s healthcare landscape while servicing both retail and institutional channels.
The anti-infective range includes therapeutics designed to combat bacterial, viral, and fungal infections, ensuring effective treatments in various healthcare settings.
This category encompasses products aimed at treating gastrointestinal disorders, helping to manage conditions such as acidity, constipation, and irritable bowel syndrome.
The cardiovascular line focuses on medications that help manage heart conditions, hypertension, and related disorders, aiming to improve patient outcomes and promote heart health.
With a variety of therapies targeting diabetes management, this product range aids patients in controlling blood sugar levels and preventing complications associated with the disease.
Offering a comprehensive selection of pain relief medications, this service addresses various pain-related conditions, ensuring patients receive effective treatment options for their pain management needs.
Aptus Pharma also provides nutraceutical products aimed at enhancing overall health and wellness, bridging the gap between nutrition and medicine.
Under the Wellcare Division, Aptus Pharma offers over-the-counter wellness products that promote general health, catering to consumers seeking preventive healthcare solutions.
The Global Division focuses on exporting products to international markets, ensuring compliance with various regulatory standards while expanding Aptus Pharma's global footprint.